Eledon Pharmaceuticals, Inc. (ELDN)
Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating innovative treatments for individuals battling autoimmune disorders, amyotrophic lateral sclerosis (ALS), and those undergoing organ or cell transplantation. Their flagship therapeutic candidate, AT-1501, is a humanized monoclonal antibody engineered to specifically target CD40 Ligand, a crucial protein found on the surface of immune system T cells. This compound is currently undergoing Phase 2a clinical studies for ALS treatment and Phase 2 trials for islet cell transplantation, aiming to address type 1 diabetes. Previously known as Novus Therapeutics, Inc., the company adopted its current name, Eledon Pharmaceuticals, Inc., in January 2021. Its corporate headquarters are located in Irvine, California.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Eledon Pharmaceuticals, Inc.
NASDAQ:ELDNHealthcare · Biotechnology
-8.88%$2.77
AH$2.93+5.68%vs close
Mkt Cap$225.09M
Float80.98M
O/S81.26M
Vol
$ Vol
RVOL
Inst Own57.7%
SI9.8%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$45.62M
Total Assets$169.01M
Free Cash Flow-$62.34M
Debt & Equity
Debt 1%
Equity 99%
Total Debt$641K
Total Equity$81.08M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:18Reverse splitOct 5, 202018 shares → 1
Balance Sheet Details
Assets$169.01M
Liabilities$87.92M
Accounts Receivable$514K
Accounts Payable$3.63M
Inventory$0
PP&E (Net)$613K
Goodwill$0
Intangible Assets$32.39M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $182K | $11K | $22K | $35K | $109K | $58 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | $0 | -$182K | -$11K | -$22K | -$35K | -$109K | -$58 | $0 | $0 |
| Gross Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research and Development | $66.27M | $51.96M | $30.31M | $27.08M | $23.73M | $6.13M | $8.13M | $6.82M | $2.02M | $25.02M | $32.64M | $14.58M | $12.2M | $7.37M |
| Selling, General, and Administrative | $16.98M | $18.61M | $12.69M | $12.7M | $13.13M | $10.05M | $5.87M | $7.24M | $11.1M | $13.1M | $12.62M | $8.88M | $3.55M | $2.28M |
| Other | $0 | $0 | $0 | $48.65M | $0 | $2.28M | $0 | -$5K | $5K | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $83.25M | $70.58M | $43M | $88.43M | $36.87M | $18.46M | $14M | $14.06M | $13.12M | $38.12M | $45.26M | $23.46M | $15.75M | $9.65M |
| Operating Income (EBIT) | -$83.25M | -$70.58M | -$43M | -$88.43M | -$36.87M | -$18.46M | -$14.18M | -$14.06M | -$13.12M | -$38.12M | -$45.26M | -$23.46M | -$15.75M | -$9.65M |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $9.66M | $0 | $0 | $0 | $0 | $174K | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | $37.67M | $34.82M | -$73.54M | $462K | $7K | -$4.75M | -$1.83M | -$5K | $5K | -$527K | $174K | $166K | $24K | $0 |
| Income Before Tax (EBT) | -$45.58M | -$35.75M | -$116.54M | -$87.97M | -$36.86M | -$23.21M | -$16.01M | -$14.06M | -$13.12M | -$37.96M | -$45.09M | -$23.3M | -$15.72M | -$9.65M |
| Income Tax Expense | $35K | $431K | $0 | $0 | -$2.35M | -$404K | $0 | -$5K | $0 | $136K | $0 | -$187K | $0 | $0 |
| Net Income | -$45.62M | -$36.18M | -$116.54M | -$87.97M | -$34.51M | -$22.81M | -$16.01M | -$14.06M | -$13.12M | -$37.96M | -$45.09M | -$23.3M | -$15.72M | -$9.65M |
| Net Income Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Supplementary Data | ||||||||||||||
| EPS | -0.56 | -0.75 | -4.73 | -6.16 | -2.33 | -17.16 | -24.42 | -28.11 | -41.40 | -398.52 | -325.62 | -583.20 | -112.33 | -68.76 |
| Diluted EPS | -0.56 | -0.75 | -4.73 | -6.16 | -2.33 | -17.16 | -24.42 | -28.11 | -41.40 | -398.52 | -325.62 | -583.20 | -112.33 | -68.76 |
| Weighted Average OS | 81.84M | 48.54M | 24.62M | 14.29M | 14.82M | 15.16M | 11.80M | 9.01M | 4.68M | 4.15M | 2.50M | 718,794 | 2.53M | 2.53M |
| EBITDA | -$45.27M | -$35.39M | -$116.16M | -$39.41M | -$36.66M | -$16M | -$15.83M | -$14.05M | -$13.1M | -$6.9M | -$44.98M | -$23.27M | -$15.71M | -$9.64M |
| EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash and Cash Equivalents | $22.81M | $20.55M | $4.61M | $56.41M | $84.83M | $114.19M | $8.79M | $12.97M | $17.23M | $23.22M | $24.02M | $105.26M | $31.75M | $11.69M |
| Short-Term Investments | $110.53M | $119.63M | $46.49M | $0 | $0 | $0 | $0 | $0 | $0 | $4.17M | $39.93M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $133.34M | $140.18M | $51.1M | $56.41M | $84.83M | $114.19M | $8.79M | $12.97M | $17.23M | $27.4M | $63.96M | $105.26M | $31.75M | $11.69M |
| Accounts Receivable | $514K | $0 | $0 | $0 | $0 | $110K | $245K | $594K | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $881K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $11K | $729K | $90K | $28K | $34K | $38K | $54K | $36K | $88K | $47K | $3.21M | $2.25M | $0 | $0 |
| Total Current Assets | $135.69M | $143.73M | $56.13M | $59.52M | $88.35M | $115.63M | $9.97M | $14.28M | $19M | $29.54M | $67.17M | $107.51M | $32.18M | $11.93M |
| Long-Term Assets | ||||||||||||||
| Property, Plant & Equipment Net | $613K | $926K | $365K | $739K | $768K | $138K | $321K | $14K | $25K | $98K | $489K | $33K | $29K | $16K |
| Goodwill | $0 | $0 | $0 | $0 | $48.65M | $48.65M | $0 | $1.87M | $1.87M | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $32.39M | $32.39M | $32.39M | $32.39M | $32.39M | $32.39M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $270K | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $322K | $363K | $186K | $150K | $400K | $383K | $639K | $869K | $0 | $120K | $45K | $200K | $80K | $20K |
| Total Long-Term Assets | $33.32M | $33.67M | $32.94M | $33.27M | $82.2M | $81.56M | $960K | $2.75M | $1.89M | $218K | $804K | $233K | $109K | $36K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $169.01M | $177.41M | $89.07M | $92.79M | $170.55M | $197.19M | $10.93M | $17.03M | $20.89M | $29.76M | $67.97M | $107.74M | $32.29M | $11.96M |
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payable | $3.63M | $5.83M | $967K | $2.2M | $1.81M | $1.37M | $329K | $689K | $418K | $338K | $1.21M | $765K | $5K | $764K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.45M | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$3.45M | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $4.18M | $1.6M | $2M | $1.91M | $1.51M | $98K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Liabilities | $18.34M | $11.58M | $3.9M | $6.47M | $4.4M | $2.48M | $1.32M | $2.53M | $1.44M | $2.82M | $6.16M | $4.24M | $2.21M | $2.02M |
| Long-Term Liabilities | ||||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $2.19M | $2.18M | $1.75M | $0 | $1.75M | $4.11M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $67.11M | $44.87M | $76.21M | $1.75M | $0 | $0 | $0 | $0 | $0 | $0 | $88K | $0 | $85.34M | $49.84M |
| Total Long-Term Liabilities | $69.58M | $47.69M | $77.96M | $2.13M | $2.15M | $4.11M | $144K | $1.84M | $1.02M | $84K | $88K | $0 | $85.34M | $49.84M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$1.84M | -$1.02M | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $87.92M | $59.27M | $81.86M | $8.61M | $6.55M | $6.59M | $1.47M | $2.53M | $1.44M | $2.9M | $6.25M | $4.24M | $87.55M | $51.86M |
| Stockholders' Equity | ||||||||||||||
| Preferred Stock | $0 | $55.69M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $19K | $302 | $0 | $0 | $0 |
| Common Stock | $75K | $60K | $24K | $14K | $14K | $15K | $13K | $9K | $7K | $23K | $23K | $22K | $0 | $0 |
| Retained Earnings | -$401.2M | -$355.59M | -$319.4M | -$202.87M | -$114.9M | -$80.39M | -$57.58M | -$41.57M | -$27.51M | -$169.4M | -$131.44M | -$86.35M | -$63.05M | -$47.33M |
| Comprehensive Income & Other | $24K | $26K | $0 | $0 | $0 | $0 | -$0 | $0 | $0 | -$1K | -$55K | -$58K | -$43K | -$51K |
| Other Stockholders' Equity | $482.21M | $473.67M | $326.59M | $287.03M | $278.88M | $270.97M | $67.03M | $56.05M | $46.95M | $196.23M | $193.14M | $189.83M | $7.79M | $7.43M |
| Total Equity | $81.08M | $118.14M | $7.21M | $84.18M | $164M | $190.6M | $9.46M | $14.49M | $19.45M | $26.86M | $61.72M | $103.5M | -$55.27M | -$39.9M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $169.01M | $177.41M | $89.07M | $92.79M | $170.55M | $197.19M | $10.93M | $17.03M | $20.89M | $29.76M | $67.97M | $107.74M | $32.29M | $11.96M |
| Supplementary Data | ||||||||||||||
| Total Debt | $641K | $954K | $383K | $746K | $769K | $144K | $324K | $0 | $0 | $3.45M | $0 | $0 | $0 | $0 |
| Net Debt | -$22.17M | -$19.59M | -$4.23M | -$55.66M | -$84.06M | -$114.05M | -$8.47M | -$12.97M | -$17.23M | -$19.78M | -$24.02M | -$105.26M | -$31.75M | -$11.69M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Operating Activities | ||||||||||||||
| Net Income | -$45.62M | -$36.18M | -$116.54M | -$87.97M | -$34.51M | -$22.81M | -$16.01M | -$14.06M | -$13.12M | -$37.96M | -$45.09M | -$23.3M | -$15.72M | -$9.65M |
| Depreciation & Amortization | $313K | $359K | $374K | $373K | $195K | $183K | $182K | $11K | $22K | $35K | $109K | $21K | $10K | $9K |
| Deferred Income Tax | $5K | $431K | $0 | $0 | -$2.35M | -$404K | $0 | $0 | $0 | $352K | $72K | $0 | -$238K | -$210K |
| Stock-Based Compensation | $10.45M | $13.12M | $6.54M | $8.15M | $7.9M | $3.17M | $1.31M | $1.54M | $579K | $3M | $2.9M | $2.11M | $238K | $210K |
| Changes in Working Capital: | ||||||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $149 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $6.72M | $7.75M | -$2.6M | $2.08M | $2.14M | -$39K | -$1.39M | $1.09M | -$1.96M | -$778K | $443K | $760K | -$759K | -$119K |
| Other Working Capital | $928K | $959K | -$2.32M | $287K | -$2.29M | -$141K | $189K | -$476K | -$517K | -$1.31M | $561K | -$556K | $760K | $216K |
| Total Working Capital Change | $7.65M | $8.71M | -$4.92M | $2.37M | -$152K | -$180K | -$1.2M | $618K | -$2.48M | -$2.08M | $1M | $204K | $1K | $97K |
| Other Non-Cash Items | -$35.15M | -$33.71M | $75.01M | $48.65M | $0 | $4.83M | $1.87M | $471K | $49K | $134K | -$235K | -$158K | $238K | $210K |
| Net Cash from Operating | -$62.34M | -$47.27M | -$39.53M | -$28.42M | -$28.91M | -$15.21M | -$13.86M | -$11.89M | -$14.94M | -$36.52M | -$41.24M | -$21.12M | -$15.48M | -$9.33M |
| Investing Activities | ||||||||||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$17K | -$565K | -$25K | -$23K | -$8K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $11.04M | $0 | $0 | $23.25M | -$2K | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$161.13M | -$156.13M | -$78.29M | $0 | $0 | $0 | $0 | $0 | $0 | -$500K | -$39.88M | $0 | $0 | $0 |
| Sales of Investments | $171.93M | $85.82M | $33M | $0 | $0 | $0 | $0 | $0 | $0 | $36.2M | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $8K | $2K | -$70K | -$150K | -$30K | $0 |
| Net Cash from Investing | $10.79M | -$70.31M | -$45.29M | $0 | $0 | $11.04M | $0 | $0 | $23.26M | $35.68M | -$40.51M | -$175K | -$53K | -$8K |
| Financing Activities | ||||||||||||||
| Debt Repaid | - | - | - | - | - | - | - | - | - | -$2.93M | - | - | - | - |
| Common Stock Issuance | $53.58M | $133.31M | $33.02M | $0 | -$449K | $9M | $9.68M | $7.49M | $4.75M | $0 | $464K | $97.93M | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | -$25K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | -$25K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $215K | $0 | $0 | $0 | $5.38M | $0 | $71K | $3.12M | $0 | $513K | -$3.13M | $185K | $4K |
| Net Cash from Financing | $53.81M | $133.52M | $33.02M | $0 | -$449K | $109.58M | $9.68M | $7.56M | $7.87M | $37K | $513K | $94.8M | $35.59M | $18.78M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $2.26M | $15.94M | -$51.8M | -$28.42M | -$29.36M | $105.4M | -$4.18M | -$4.33M | $16.19M | -$800K | -$81.23M | $73.5M | $20.06M | $9.44M |
| Supplementary Data | ||||||||||||||
| Operating Cash Flow | -$62.34M | -$47.27M | -$39.53M | -$28.42M | -$28.91M | -$15.21M | -$13.86M | -$11.89M | -$14.94M | -$36.52M | -$41.24M | -$21.12M | -$15.48M | -$9.33M |
| Capital Expenditure | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$17K | -$565K | -$25K | -$23K | -$8K |
| Free Cash Flow | -$62.34M | -$47.27M | -$39.53M | -$28.42M | -$28.91M | -$15.21M | -$13.86M | -$11.89M | -$14.94M | -$36.54M | -$41.8M | -$21.15M | -$15.5M | -$9.34M |
| Cash at Beginning | $20.55M | $4.61M | $56.41M | $84.83M | $114.19M | $8.79M | $12.97M | $17.3M | $1.12M | $24.02M | $105.26M | $31.75M | $11.69M | $2.25M |
| Cash at End | $22.81M | $20.55M | $4.61M | $56.41M | $84.83M | $114.19M | $8.79M | $12.97M | $17.3M | $23.22M | $24.02M | $105.26M | $31.75M | $11.69M |